|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online May 28, 2005
doi: 10.1242/10.1242/jcs.02357
Research Article |
-converting enzyme and its potential role in TACE protein trafficking
1 University of Cambridge, Department of Oncology, Cambridge Institute of Medical Research, Hills Road, Cambridge, CB2 2XY, UK
2 Center for Experimental Therapeutics, University of Pennsylvania School of Medicine, 421 Curie Blvd, Philadelphia, PA 19104, USA
3 National Jewish Medical and Research Center, Department of Pediatrics, 1400 Jackson Street, Colorado 80206, USA
* Author for correspondence (e-mail: sms45{at}cam.ac.uk)
Accepted 2 March 2005
Tumor necrosis factor 
-converting enzyme (TACE/ADAM17) has been implicated in the inducible shedding of numerous cell surface proteins. In light of this, the regulation of TACE catalytic activation and protein maturation has recently received considerable interest in the context of extracellular signal-regulated kinase activation and the subsequent phosphorylation of TACE at residue Thr735. In this study, we analysed the subcellular localisation of TACE derivatives using laser-scanning confocal microscopy and cell surface biotinylation. Whereas WT.TACE- and T735A.TACE-enhanced green fluorescent protein (-eGFP) fusion derivatives of TACE were both found to localise with the endoplasmic reticulum, a phosphomimicking form of TACE (T735E.TACE-eGFP) was found to colocalise predominantly with components of the protein secretory pathway (COPII vesicles and trans-Golgi network). Additionally, upon analysis of biotinylated ectopic TACE, we observed that inducible trafficking of TACE to the cell surface was dependent upon extracellular signal-regulated kinase activation and phosphorylation of Thr735. We conclude from our observations that phosphorylation of TACE at Thr735 highlights a key step in inducible TACE protein trafficking and maturation.
Key words: ERK, MAP kinase, TACE phosphorylation, TACE trafficking
This article has been cited by other articles:
|
|
 |
|
  W. B.W.H. Melenhorst, G. M. Mulder, Q. Xi, J. G.J. Hoenderop, K. Kimura, S. Eguchi, and H. van Goor Epidermal Growth Factor Receptor Signaling in the Kidney: Key Roles in Physiology and Disease Hypertension, December 1, 2008; 52(6): 987 - 993. [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Ford, I. M. Mains, E. J. Hilton, S. T. Reeves, R. E. Stroud, F. A. Crawford Jr, J. S. Ikonomidis, and F. G. Spinale Endothelin-A Receptor Inhibition After Cardiopulmonary Bypass: Cytokines and Receptor Activation Ann. Thorac. Surg., November 1, 2008; 86(5): 1576 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Wang, B. Xiang, M. Guix, M. G. Olivares, J. Parker, C. H. Chung, A. Pandiella, and C. L. Arteaga Transforming Growth Factor {beta} Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab Mol. Cell. Biol., September 15, 2008; 28(18): 5605 - 5620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. West, A. R. Prescott, K. M. Chan, Z. Zhou, S. Rose-John, J. Scheller, and C. Watts TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent J. Cell Biol., September 8, 2008; 182(5): 993 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Levine Molecular Mechanisms of Soluble Cytokine Receptor Generation J. Biol. Chem., May 23, 2008; 283(21): 14177 - 14181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Paland, L. Bohme, R. K. Gurumurthy, A. Maurer, A. J. Szczepek, and T. Rudel Reduced Display of Tumor Necrosis Factor Receptor I at the Host Cell Surface Supports Infection with Chlamydia trachomatis J. Biol. Chem., March 7, 2008; 283(10): 6438 - 6448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rousseau, M. Papoutsopoulou, A. Symons, D. Cook, J. M. Lucocq, A. R. Prescott, A. O'Garra, S. C. Ley, and P. Cohen TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF{alpha} in LPS-stimulated macrophages J. Cell Sci., January 15, 2008; 121(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chalaris, B. Rabe, K. Paliga, H. Lange, T. Laskay, C. A. Fielding, S. A. Jones, S. Rose-John, and J. Scheller Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils Blood, September 15, 2007; 110(6): 1748 - 1755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alfa Cisse, C. Sunyach, B. E. Slack, A. Fisher, B. Vincent, and F. Checler M1 and M3 Muscarinic Receptors Control Physiological Processing of Cellular Prion by Modulating ADAM17 Phosphorylation and Activity J. Neurosci., April 11, 2007; 27(15): 4083 - 4092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Forsyth, A. Banan, A. Farhadi, J. Z. Fields, Y. Tang, M. Shaikh, L. J. Zhang, P. A. Engen, and A. Keshavarzian Regulation of Oxidant-Induced Intestinal Permeability by Metalloprotease-Dependent Epidermal Growth Factor Receptor Signaling J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 84 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Horiuchi, S. Le Gall, M. Schulte, T. Yamaguchi, K. Reiss, G. Murphy, Y. Toyama, D. Hartmann, P. Saftig, and C. P. Blobel Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx Mol. Biol. Cell, January 1, 2007; 18(1): 176 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ohtsu, P. J. Dempsey, and S. Eguchi ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors Am J Physiol Cell Physiol, July 1, 2006; 291(1): C1 - C10. [Abstract] [Full Text] [PDF]
|
|
